| 25/07/23 | 07:00:06 | 25 Jul 2023 | | Flu B challenge model |
| 28/06/23 | 07:00:03 | 28 Jun 2023 | | hMPV human challenge model |
| 14/06/23 | 08:00:01 | 14 Jun 2023 | | Director dealings |
| 23/05/23 | 12:36:08 | 23 May 2023 | | Result of AGM |
| 28/04/23 | 07:00:09 | 28 Apr 2023 | | Annual Report and Notice of AGM |
| 26/04/23 | 07:00:11 | 26 Apr 2023 | | FDA Breakthrough and Fast Track for US biotech |
| 25/04/23 | 07:00:07 | 25 Apr 2023 | | Final results |
| 19/04/23 | 07:10:55 | 19 Apr 2023 | | Notice of Results |
| 06/04/23 | 15:54:40 | 6 Apr 2023 | | Holding(s) in Company |
| 03/04/23 | 07:00:17 | 3 Apr 2023 | | Positive results from flu human challenge study |
| 29/03/23 | 07:00:06 | 29 Mar 2023 | | Presentation at World Vaccine Congress |
| 23/03/23 | 07:00:03 | 23 Mar 2023 | | Exercise of Options |
| 16/03/23 | 07:00:05 | 16 Mar 2023 | | Omicron human challenge model update |
| 06/02/23 | 09:05:52 | 6 Feb 2023 | | Second Price Monitoring Extn |
| 06/02/23 | 09:00:35 | 6 Feb 2023 | | Price Monitoring Extension |
| 06/02/23 | 07:05:01 | 6 Feb 2023 | | Long Term Incentive Plan / PDMR Notification |
| 06/02/23 | 07:00:02 | 6 Feb 2023 | | £6.8m RSV human challenge contract signed |
| 25/01/23 | 09:06:01 | 25 Jan 2023 | | Second Price Monitoring Extn |
| 25/01/23 | 09:00:31 | 25 Jan 2023 | | Price Monitoring Extension |
| 25/01/23 | 07:00:04 | 25 Jan 2023 | | Trading update |
| 17/01/23 | 07:00:06 | 17 Jan 2023 | | EUR3.2m Venn contract with global pharma client |
| 04/01/23 | 16:40:55 | 4 Jan 2023 | | Second Price Monitoring Extn |
| 04/01/23 | 16:35:31 | 4 Jan 2023 | | Price Monitoring Extension |
| 04/01/23 | 07:00:03 | 4 Jan 2023 | | £5.2m RSV contract and Notice of Trading update |
| 03/01/23 | 16:40:17 | 3 Jan 2023 | | Second Price Monitoring Extn |
| 03/01/23 | 16:35:15 | 3 Jan 2023 | | Price Monitoring Extension |
| 03/01/23 | 14:05:48 | 3 Jan 2023 | | Second Price Monitoring Extn |
| 03/01/23 | 14:00:29 | 3 Jan 2023 | | Price Monitoring Extension |
| 03/01/23 | 11:05:22 | 3 Jan 2023 | | Second Price Monitoring Extn |
| 03/01/23 | 11:00:10 | 3 Jan 2023 | | Price Monitoring Extension |
| 19/12/22 | 07:00:08 | 19 Dec 2022 | | Imutex Phase I data published |
| 17/11/22 | 14:05:53 | 17 Nov 2022 | | Second Price Monitoring Extn |
| 17/11/22 | 14:00:38 | 17 Nov 2022 | | Price Monitoring Extension |
| 11/11/22 | 07:00:06 | 11 Nov 2022 | | Exercise of Options |
| 10/11/22 | 11:00:48 | 10 Nov 2022 | | Price Monitoring Extension |
| 10/11/22 | 08:22:04 | 10 Nov 2022 | | £13.6m RSV antiviral contract |
| 04/11/22 | 07:25:43 | 4 Nov 2022 | | Holding(s) in Company |
| 25/10/22 | 07:00:06 | 25 Oct 2022 | | Change of name to hVIVO plc effective |
| 20/10/22 | 07:00:04 | 20 Oct 2022 | | Capital Markets Day |
| 18/10/22 | 07:00:06 | 18 Oct 2022 | | CFO appointment & change of Board roles |
| 30/09/22 | 07:00:19 | 30 Sept 2022 | | Positive in vitro results for FLU-v published |
| 29/09/22 | 09:30:01 | 29 Sept 2022 | | Director dealings |
| 27/09/22 | 07:00:12 | 27 Sept 2022 | | Upcoming Scientific Presentations |
| 15/09/22 | 07:00:08 | 15 Sept 2022 | | Comment regarding press speculation |
| 08/09/22 | 07:01:05 | 8 Sept 2022 | | Interim results and trading update |
| 08/09/22 | 07:00:15 | 8 Sept 2022 | | Intention to change name to hVIVO plc |
| 01/09/22 | 07:20:24 | 1 Sept 2022 | | CAP accreditation |
| 25/08/22 | 07:00:04 | 25 Aug 2022 | | Notice of results |
| 22/08/22 | 07:00:05 | 22 Aug 2022 | | £10.4m contract with existing Big Pharma client |
| 04/08/22 | 07:00:07 | 4 Aug 2022 | | £6.2m Influenza human challenge study contract |
